[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0510963D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0510963D0
GB0510963D0 GB0510963A GB0510963A GB0510963D0 GB 0510963 D0 GB0510963 D0 GB 0510963D0 GB 0510963 A GB0510963 A GB 0510963A GB 0510963 A GB0510963 A GB 0510963A GB 0510963 D0 GB0510963 D0 GB 0510963D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0510963A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0510963A priority Critical patent/GB0510963D0/en
Publication of GB0510963D0 publication Critical patent/GB0510963D0/en
Priority to EP06727154A priority patent/EP1888572A1/en
Priority to US11/914,474 priority patent/US20080194556A1/en
Priority to CN2006800187685A priority patent/CN101184751B/en
Priority to JP2008514177A priority patent/JP2008542345A/en
Priority to PCT/GB2006/001911 priority patent/WO2006129064A1/en
Priority to UY29561A priority patent/UY29561A1/en
Priority to TW095118869A priority patent/TW200716618A/en
Priority to ARP060102205A priority patent/AR056369A1/en
Ceased legal-status Critical Current

Links

GB0510963A 2005-05-28 2005-05-28 Chemical compounds Ceased GB0510963D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0510963A GB0510963D0 (en) 2005-05-28 2005-05-28 Chemical compounds
EP06727154A EP1888572A1 (en) 2005-05-28 2006-05-24 Quinazolines and their use as aurora kinase inhibitors
US11/914,474 US20080194556A1 (en) 2005-05-28 2006-05-24 Quinazolines and Their Use as Aurora Kinase Inhibitors
CN2006800187685A CN101184751B (en) 2005-05-28 2006-05-24 Quinazolines and their use as AURORA kinase inhibitors
JP2008514177A JP2008542345A (en) 2005-05-28 2006-05-24 Quinazolines and their use as Aurora kinase inhibitors
PCT/GB2006/001911 WO2006129064A1 (en) 2005-05-28 2006-05-24 Quinazolines and their use as aurora kinase inhibitors
UY29561A UY29561A1 (en) 2005-05-28 2006-05-25 DERIVATIVES OF QUINAZOLINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS
TW095118869A TW200716618A (en) 2005-05-28 2006-05-26 Chemical compounds
ARP060102205A AR056369A1 (en) 2005-05-28 2006-05-26 COMPOUNDS DERIVED FROM QUINAZOLINE AND PHARMACEUTICAL COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0510963A GB0510963D0 (en) 2005-05-28 2005-05-28 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0510963D0 true GB0510963D0 (en) 2005-07-06

Family

ID=34834814

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0510963A Ceased GB0510963D0 (en) 2005-05-28 2005-05-28 Chemical compounds

Country Status (2)

Country Link
CN (1) CN101184751B (en)
GB (1) GB0510963D0 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922173D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
CZ20024120A3 (en) * 2000-06-28 2003-03-12 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors
CN100491372C (en) * 2001-12-24 2009-05-27 阿斯特拉曾尼卡有限公司 Substituted quinazoline derivatives as inhibitors of aurora kinases
BRPI0409427A (en) * 2003-04-16 2006-04-18 Astrazeneca Ab compound, use thereof, pharmaceutical composition, method of treating a human suffering from a hyperproliferative disease, and process for the preparation of a compound or a pharmaceutically acceptable salt, ester or prodrug thereof

Also Published As

Publication number Publication date
CN101184751B (en) 2012-08-15
CN101184751A (en) 2008-05-21

Similar Documents

Publication Publication Date Title
EP1951217A4 (en) Chemical compounds
EP1951250A4 (en) Chemical compounds
GB0504753D0 (en) Chemical compounds
EP1919872A4 (en) Chemical compounds
GB0503056D0 (en) Chemical compounds
GB0511266D0 (en) Chemical compounds
EP1853604A4 (en) Chemical compounds
EP1940394A4 (en) Chemical compounds
GB0514018D0 (en) Chemical compounds
EP1959737A4 (en) Chemical compounds
GB0503053D0 (en) Chemical compounds
EP1948187A4 (en) Chemical compounds
EP1896014A4 (en) Chemical compounds
GB0503054D0 (en) Chemical compounds
GB0510852D0 (en) Chemical compounds
GB0514017D0 (en) Chemical compounds
GB0504475D0 (en) Chemical compounds
GB0504474D0 (en) Chemical compounds
GB0506886D0 (en) Chemical compounds
GB0507200D0 (en) Chemical compounds
GB0500301D0 (en) Chemical compounds
GB0514174D0 (en) Chemical compounds
GB0511851D0 (en) Chemical compounds
GB0507347D0 (en) Chemical compounds
GB0506883D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)